Homepage
FRESH Analysis Report
Jun 12, 2026
today · 100% complete · +6 refreshed

Kyndryl Holdings, Inc.

KD NYSE Categories PDF
Technology · Information Technology Services
New York City, NY 10017, United States IPO 2021 kyndryl.com Updated Jun 12, 3:00am
Price
$11.28
Market Cap
$2.5B
Employees
80,000
Beta
1.73
Avg Volume
3,964,817
CEO
Martin J. Schroeter
Business Description

Kyndryl Holdings, Inc. functions as a global technology and IT infrastructure services specialist. The firm delivers a comprehensive portfolio of IT solutions, encompassing cloud computing, foundational enterprise platforms, application development, data analytics, and artificial intelligence capabilities. Additionally, Kyndryl provides services related to modern digital workplaces, robust security and resiliency, alongside advanced network and edge computing solutions. It caters to a diverse clientele across various sectors such as finance, telecommunications, retail, automotive, and logistics. Established in 2020, its corporate headquarters are situated in New York, New York.

Business History
Generated: Jun 12, 2026 3:03am
Price Overview
Last updated: Jun 12, 2026 3:00am (22h ago)
$11.28
+0.03 (+0.27%)
Day Range
$10.98 – $11.28
52-Week Range
$10.10 – $44.20
50-Day MA
$12.75
200-Day MA
$21.18
Volume
3,066,907.00
Analyst Price Targets
Low $13.00
Consensus $17.75
High $28.00
(14 analysts)
Share Structure
Outstanding 219,918,196.00
Float 202,359,927.00
Free Float 92.0%
High free float — 92.0% of shares trade freely, ~8% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jun 12, 2026 3:07am (22h ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 12, 2026 3:07am (22h ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
Industry comparison last run: Jun 12, 2026 3:02am
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
12.81
Stock Price: $11.28
EPS (Diluted): 0.87
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
2.55
Stock Price: $11.28
Total Equity: $1.18B
Shares: 233,800,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
1.79
Market Cap: $2.48B
Total Debt: $4.09B
Cash: $2.62B
EBITDA: $3.28B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$5.3B
Market Cap: $2.48B
Total Debt: $4.09B
Cash: $2.62B
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
21.8%
Gross Profit: $3.29B
Revenue: $15.09B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
4.2%
Operating Income: $635.00M
Revenue: $15.09B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
1.3%
Net Income: $198.00M
Revenue: $15.09B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
16.4%
Net Income: $198.00M
Total Equity: $1.18B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
3.7%
Operating Income: $635.00M
Tax Rate: 51.9%
Equity: $1.18B
Total Debt: $4.09B
Cash: $2.62B
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
0.88
Current Assets: $5.53B
Current Liabilities: $6.31B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
3.48
Short-Term Debt: $1.80B
Long-Term Debt: $2.29B
Total Debt: $4.09B
Total Equity: $1.18B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$64.55
Revenue: $15.09B
Shares: 233,800,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$5.03
Total Equity: $1.18B
Shares: 233,800,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$1.45
Operating CF: $948.00M
CapEx: -$608.00M
Shares: 233,800,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $11.28
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $198.00M
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 12, 2026 3:02am
Compares KD against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis
Last run: Jun 12, 2026 3:06:43 am

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for Mature Earner companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for Mature Earner companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for Mature Earner companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for Mature Earner companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for Mature Earner companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for Mature Earner companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 12, 2026 3:07am (22h ago)
Metric 2022 2023 2024 2025 2026
Revenue $18.7B $17.0B $16.1B $15.1B $15.1B
Cost of Revenue $16.6B $14.5B $13.2B $11.9B $11.8B
Gross Profit $2.1B $2.5B $2.9B $3.1B $3.3B
Operating Expenses $2.8B $2.9B $2.8B $2.6B $2.7B
Operating Income -$669.0M -$386.0M $90.0M $552.0M $635.0M
Net Income -$2.3B -$1.4B -$340.0M $252.0M $198.0M
EBITDA -$175.0M $617.0M $1.1B $1.6B $3.3B
EPS $-10.28 $-6.06 $-1.48 $1.09 $0.87
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 12, 2026 3:03am (22h ago)
Metric 2022 2023 2024 2025 2026
Cash & Equivalents $2.2B $1.8B $1.6B $1.8B $2.6B
Total Current Assets $5.8B $5.0B $4.7B $4.6B $5.5B
Total Assets $13.2B $11.5B $10.6B $10.5B $12.6B
Current Liabilities $4.5B $4.9B $4.6B $4.3B $6.3B
Long-Term Debt $3.1B $3.1B $3.1B $3.0B $2.3B
Total Liabilities $10.4B $10.0B $9.5B $9.1B $11.3B
Total Equity $2.8B $1.4B $1.0B $1.2B $1.2B
Retained Earnings -$375.0M -$2.0B -$2.3B -$2.1B -$1.9B
Cash Flow (Annual)
Last updated: Jun 12, 2026 3:07am (22h ago)
Metric 2021 2023 2024 2025 2026
Operating Cash Flow -$119.0M $454.0M $454.0M $942.0M $948.0M
Capital Expenditure -$752.0M -$651.0M -$651.0M -$605.0M -$608.0M
Free Cash Flow -$871.0M -$197.0M -$197.0M $337.0M $340.0M
Acquisitions (net) $0 $0 $0 $139.0M $66.0M
Debt Repayment
Dividends Paid
Stock Buybacks -$1.0M -$22.0M -$22.0M -$138.0M -$398.0M
Net Change in Cash $2.2B -$306.0M -$306.0M $235.0M $834.0M
Analyst Estimates (Annual)
Last updated: Jun 12, 2026 3:00am (22h ago)
Metric 2026 2027 2028 2029
Revenue $15.1B
$15.0B – $15.1B
$14.9B
$14.6B – $15.1B
$15.0B
$14.4B – $15.4B
$15.2B
$15.2B – $15.2B
EBITDA $6.4B
$6.4B – $6.5B
$6.4B
$6.2B – $6.5B
$6.4B
$6.1B – $6.6B
$6.5B
$6.5B – $6.5B
Net Income $414.6M
$393.2M – $436.1M
$420.0M
$389.3M – $450.7M
$589.4M
$535.0M – $643.9M
$637.3M
$621.3M – $653.3M
EPS
Growth Trends (YoY %)
Last updated: Jun 12, 2026 3:07am (22h ago)
Metric 2023 2024 2025 2026
Revenue Growth -8.7% -5.7% -6.2% +0.2%
Gross Profit Growth +20.0% +13.3% +9.8% +4.6%
Operating Income Growth +42.3% +123.3% +513.3% +15.0%
Net Income Growth +40.4% +75.3% +174.1% -21.4%
EBITDA Growth +452.6% +84.3% +36.5% +111.2%
Insider Trading (Recent)
Last updated: Jun 12, 2026 3:06am (22h ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-03 Ringes Mark F-InKind 525.00 $12.25 $6,431
2026-06-03 Paulek Mark D F-InKind 437.00 $12.25 $5,353
2026-06-03 Keinan Elly F-InKind 13,894.00 $12.25 $170,202
2026-06-03 Chugh Harsh F-InKind 651.00 $12.25 $7,975
2026-06-03 Schroeter Martin J F-InKind 19,407.00 $12.25 $237,736
2026-06-01 Schroeter Martin J A-Award 496,063.00 $0.00 $0
2026-06-02 Schroeter Martin J F-InKind 20,776.00 $12.62 $262,193
2026-06-01 Chugh Harsh A-Award 55,119.00 $0.00 $0
2026-06-02 Chugh Harsh F-InKind 1,157.00 $12.62 $14,601
2026-05-28 Keinan Elly A-Award 309,440.00 $0.00 $0
2026-05-28 Keinan Elly F-InKind 158,786.00 $12.16 $1.9M
2026-05-28 Schroeter Martin J A-Award 427,516.00 $0.00 $0
2026-05-28 Schroeter Martin J F-InKind 205,913.00 $12.16 $2.5M
2026-05-28 Paulek Mark D A-Award 36,646.00 $0.00 $0
2026-05-28 Paulek Mark D F-InKind 10,757.00 $12.16 $130,805
2026-05-28 Ringes Mark A-Award 10,023.00 $0.00 $0
2026-05-28 Ringes Mark F-InKind 3,615.00 $12.16 $43,958
2026-05-28 Chugh Harsh A-Award 40,718.00 $0.00 $0
2026-05-28 Chugh Harsh F-InKind 9,917.00 $12.16 $120,591
2026-04-01 Paulek Mark D 0.00 $0.00 $0
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for KD.
Delvantic AI Findings
Independent analyst synthesis · Delvantic - Cairn AI · generated 2026-06-12 03:07:16
Reviews the pipeline's own verdicts
Verdict Undervalued deep-value turnaround — fair value $18-22 vs $11.28 on stabilized FCF; starter position warranted pending debt confirmation, dissent from synthesis "avoid."

The raw numbers tell a more interesting story than "melting ice cube." Revenue has stabilized hard: FY2026 at $15.09B vs FY2025 at $15.06B — essentially flat after three years of 5-8% declines. The quarterly cadence is also stable in a $3.7-3.9B band for eight straight quarters. Gross margin expanded from 11.3% (FY22) to 21.8% (FY26), and operating income swung from -$669M to +$635M — a $1.3B swing on a shrinking revenue base. That's not a melting ice cube; that's a completed restructuring. Operating CF of $948M and FCF of $340M on a $2.48B market cap is a 13.7% FCF yield. EV/EBITDA of 1.79x is genuinely distressed-multiple territory for a company that just posted positive net income two years running.

The synthesis verdict ("Disconnected from Fundamentals") and Market Forces ("avoid") are, in my read, fighting the last war. They're anchored on the FY22-FY24 disaster and the revenue decline narrative. But the most recent quarter (Q1 FY27, period ending 2026-03-31 — note the fiscal calendar) shows revenue +0.8% YoY and the trailing four quarters are flat-to-slightly-up. The Pre-Flight "deep-value-turnaround" framing is closer to right than the synthesis layer's dismissal. Where I'd push back on Pre-Flight: the most recent quarter's net margin collapsed to 0.5% from 1.8% sequentially, and FY24 NI of $215M in Q3 looks like a tax/one-time benefit (it dwarfs every other quarter), which means the "improving profitability" trajectory is lumpier than the annual roll-up suggests. Strip that quarter and TTM NI is closer to $150M, not $198M, and the P/E moves from 12.8x toward ~16x.

The contrarian-to-contrarian case: IT services is structurally challenged by hyperscalers and offshore consultancies; Kyndryl's $15B revenue base includes a large IBM-mainframe-adjacent book that has real long-tail decay risk. The balance sheet tile is blank on total debt and equity — that's the single biggest analytical gap here. Kyndryl carried roughly $3B+ in long-term debt post-spin; without confirming current leverage, the EV/EBITDA of 1.79x could be understating enterprise value materially. Current ratio of 0.88 is a yellow flag for a services business. The insider activity is entirely awards and tax-withholding (F-InKind), zero open-market buying — management isn't signaling conviction at $11.28 either. And the Narrative layer is right that this is "fragile" — one bad quarter and the bid disappears because there's no cult holding it.

Net: I dissent from the synthesis "Disconnected from Fundamentals / avoid" verdict. The math is too cheap to dismiss. 0.20x sales, 1.8x EV/EBITDA, 13.7% FCF yield, and revenue that has demonstrably stopped declining is the textbook setup for a deep-value re-rating — not a guaranteed one, but the risk/reward asymmetry is favorable. Fair value on a normalized basis: if FY27 FCF holds at $350-400M and the market grants even a modest 8% FCF yield (still cheap for stabilized services), that's $4.4-5.0B equity value, or $20-22/share — roughly 80-95% upside. The bear case requires revenue to resume declining AND margins to compress, which the last eight quarters don't support. I'd want to verify total debt before sizing, but the prior models are overweighting the legacy decline story and underweighting that the stabilization has already happened on the tape.

GPT Critique
Second-opinion review · gpt-4o · generated 2026-06-12 03:07:21
Reviews the Opus findings above
Verdict I agree with Opus on the undervaluation thesis at $11.28 due to improved financials, but I am more cautious; fair value closer to $16-18 pending debt confirmation, highlighting potential leverage concerns and earnings volatility.

Kyndryl Holdings' financial performance indicates a company undergoing significant transformation. Revenues have stabilized at around $15 billion annually after a sharp decline from $18.66 billion in 2022. This stabilization, coupled with a notable improvement in gross margins from 11.3% in 2022 to 21.8% in 2026, suggests a successful restructuring. Operating income has turned positive, reaching $635 million in 2026 from a loss of $669 million in 2022. This turnaround is underscored by a decent free cash flow of $340 million, giving a substantial FCF yield relative to its market cap. The low EV/EBITDA ratio of 1.79x further supports the notion that Kyndryl is trading at distressed levels, potentially undervaluing the company if its restructuring efforts hold.

I agree with Opus that Kyndryl's narrative as a "melting ice cube" is misleading given the evidence of revenue stabilization and margin improvement. Indeed, the company's recent financials reflect a completed restructuring rather than a business in decline. However, I disagree with Opus's view that the FCF yield and EV/EBITDA are sufficient indicators for undervaluation without considering the missing debt figures. The absence of total debt and equity data is a significant oversight, as it directly affects the enterprise value calculation and risk assessment. Opus emphasizes the potential undervaluation based on FCF yield and EV multiples, but these metrics could be misleading if leverage is higher than assumed.

Moreover, Opus rightly questions the sustainability of profitability improvements, noting the variability in net income, particularly the anomalous Q3 FY24 net income. This skepticism is warranted as the recent quarter's net margin fell to 0.5% from 1.8%, highlighting potential volatility in earnings. Therefore, while I concur with Opus that the recent financials show promise, there's a need for caution in assuming this trend will persist without further evidence of debt stabilization.

A skeptic might argue that Kyndryl's challenges remain significant. The company's reliance on legacy IBM contracts and the threat from more agile competitors could pressure both revenue and margins. Furthermore, the lack of insider buying despite the low share price may imply management's uncertainty about the company's prospects. The fragile narrative and current ratio of 0.88 also suggest potential liquidity issues, adding to the risk profile.

Advanced Analysis Forensic deep-dive · two lenses
Two separate reads — Company Quality (is it a great business?) and Valuation (is it mispriced?), kept deliberately apart · 2026-06-12 03:08:46
Delvantic - Cairn AI
Starter position — scale in lower 6/10
A real but fragile turnaround that's modestly cheap at $11 — interesting, not a fat pitch until it's under $9 or revenue stabilizes.
The cruxWhether revenue stops shrinking before the levered balance sheet forces a misstep — top-line stabilization is what unlocks both a higher multiple and a bigger margin of safety.
Company Quality
+5
Mixed
edge √Σ 117 · risk √Σ 112 · conf 6/10
Valuation / Mispricing
+15
Modestly Cheap
edge √Σ 77 · risk √Σ 62 · conf 5/10
Liquidity & RunwaySelf-Funding
DilutionStable Share Count
Earnings QualityGood Earnings Quality
The Play — combined read across both lenses Delvantic - Cairn AI

Quality at 5 and Value at 15 are telling a consistent story: this is a genuine operational turn (margin curve up four straight years, FCF inflected, clean accruals, Beneish fine) wrapped in a sub-scale, 4%-margin, Altman-distress-zone services carve-out that's still shrinking on the top line. At $11.28 I'm getting maybe 20–35% upside to a deserved $13–16, which is real but not the 2x asymmetry I want when equity sits behind $1.5B of net debt in a commoditized industry. The market is pricing the pre-turn IBM stepchild; reality is somewhere between that and a self-funding services business — and the gap, while genuine, deserves a balance-sheet haircut.

My play: open a starter at ~25–33% of target weight here (call it 50–75 bps in a diversified book), and explicitly reserve the rest for sub-$9, which is where Lens 2 says it becomes a fat pitch and where I'd back up the truck to a full 2% position. I add aggressively on any quarter that shows revenue flat-to-up year-over-year with margins holding — that's the catalyst that re-rates this from 'distressed carve-out' to 'self-funding services compounder.' I cut and walk if FCF rolls back negative, if they do a dilutive raise to plug the balance sheet, or if operating margin gives back more than ~100bps. No insider buying and a still-shrinking top line keep me from getting cute with size today — this is a measured nibble on a real inflection, not a conviction pound-the-table call.

The evidence behind each score — switch lenses
+5 Mixed edge √Σ 117 · risk √Σ 112 · conf 6/10

Kyndryl, the 2021 IBM managed-infrastructure spinoff, has executed a real operational turn. Gross margin has climbed every single year from 11.3% (2022) to 21.8% (2026), operating margin has swung from -3.6% to +4.2%, and the company crossed into GAAP profitability in 2025 ($252M net income) with $337-340M FCF in the last two years versus cumulative FCF losses of ~$1.27B in the prior three. OCF/NI of 1.38x and accruals of -10.5% of assets say the reported earnings are backed by cash, not accounting sugar, and Beneish M of -2.8 shows no manipulation flags.

The catch is that this is a low-margin IT services business (4% operating margin even after the turnaround) running on a constrained balance sheet: net debt of $1.47B against only $340M of annual FCF, and an Altman Z of 1.22 in the textbook distress zone. Revenue is still contracting on an absolute basis ($18.66B → $15.09B over five years), so the margin gains are coming from shedding unprofitable contracts rather than growth. Dilution is mild (~1.1% CAGR) and buybacks exceed SBC (160.9% ratio), which is shareholder-friendly, but the insider tape is purely award/withholding activity with no open-market conviction buys.

Net: a legitimate self-help story with clean accounting, but not yet a fortress and not yet a proven grower. Quality is improving, not proven.

Strengths 4
m75
Sustained margin expansion
Gross margin up every year 11.3% → 14.8% → 17.8% → 20.9% → 21.8%; operating margin -3.6% → +4.2%. That is four consecutive years of structural improvement, not a one-off.
m70
FCF inflection is real
FCF swung from -$871M/-$197M/-$197M to +$337M/+$340M. OCF/NI of 1.38x and -10.5% accruals say the earnings are cash-backed, not accrual-flattered.
m45
Clean earnings quality signals
Beneish M of -2.8 (well below the -1.78 manipulation threshold) and good earnings-quality score; no signs of channel-stuffing or accrual games during the turn.
m35
Disciplined share count
Diluted share CAGR 1.1%, buyback/SBC ratio 160.9% — management is actually mopping up dilution rather than letting it compound.
Concerns 5
m70
Balance sheet still a constraint
Net debt of $1.47B with Altman Z of 1.22 in distress territory. $340M FCF covers it but leaves little room for error in a capital-intensive services business.
m65
Revenue still shrinking
Revenue declined every year from $18.66B (2022) to $15.06B (2025), then flat at $15.09B (2026). Margin gains come from contract pruning, not demand — durability of the model unproven once the easy cuts are done.
m50
Structurally low-margin business
Even post-turnaround, operating margin is only 4.2% on $15B of revenue. IT infrastructure services is commoditized vs. hyperscalers and competitors like Accenture/DXC — no obvious moat visible in the numbers.
m25
No insider conviction
Last 12 months: zero open-market buys, only one small $177K sale plus routine award/withholding activity. Management isn't signaling belief with their own cash.
m20
Short operating history as a standalone
Only ~5 years of public financials post-IBM spin; the 2026 net income of $198M is actually down from $252M in 2025 — too early to say profitability trajectory is monotonic.
This is a genuine turnaround, not a fake one — the margin curve is too consistent and the cash conversion too clean for it to be accounting theater. But let's be honest about what the business is: a sub-scale, low-margin IT infrastructure services company carved out of IBM, still shrinking on the top line, sitting in the Altman distress zone, with 4% operating margins in a commoditized industry. The accounting is honest, the dilution is controlled, and management has done real work. It's not a great business — it's an improving okay business with a constrained balance sheet. Mixed feels right; calling it Solid would be premature until I see revenue actually grow and the net debt come down.
Verify before trusting this (6)
  • Composition of $1.47B net debt — maturity ladder, fixed vs. floating, covenants
  • Whether the revenue stabilization in 2026 reflects end of contract pruning or genuine demand return (signings/book-to-bill)
  • Customer concentration — legacy IBM-related revenue % and renewal economics
  • Pension/OPEB liabilities inherited from IBM spin (often material for Altman Z in services co's)
  • Segment-level margins (Kyndryl Consult vs. core managed services) to test whether mix shift is driving margin gains
  • Capex intensity — is the FCF sustainable or aided by underinvestment in delivery infrastructure?
+15 Modestly Cheap edge √Σ 77 · risk √Σ 62 · conf 5/10
Price $11.28 vs deserved ~$13–16 — roughly 15–35% upside to fair, a real but not screaming margin of safety. attractive below $9.00

The setup is a fallen-angel carve-out trading at ~0.13x sales with a market cap of $2.5B against $19B of revenue and freshly-inflected positive FCF. If you give the business even a mid-single-digit EV/EBITDA on a normalized ~4% operating margin base, deserved equity value lands meaningfully north of $11 — call it $13–16 — once you net out net debt. The e2e synthesis flagged 'Disconnected from Fundamentals,' which I read as the methods diverging wildly (typical for low-margin, high-revenue carve-outs); I'm not anchoring on any single DCF print here.

What's priced in at $11.28 is essentially: revenue keeps shrinking, margins stall around 4%, and the balance sheet stays in the Altman distress zone. That's a plausible bear case, not a heroic one — which is why I can't call this Deep Value. The turnaround is real (clean cash conversion, consistent margin curve) but it's early and sub-scale in a commoditized industry. The gap to deserved value exists but it's a 20–40% gap, not a 2x gap, and it comes with real balance-sheet risk that should haircut the multiple.

Net: modestly cheap, not a fat pitch. You're paid to wait if execution continues, but you're not getting a Graham-style margin of safety.

Cheap signals 3
m55
Tiny market cap on $19B revenue base
$2.48B market cap / $19B revenue = 0.13x sales. Even modest sustained 4% operating margins imply ~$760M operating income against a $2.5B equity stub — the multiple is punitively low if the inflection holds.
m45
Margin and FCF inflection not yet in the multiple
Quality lens confirms margins and FCF have genuinely inflected positive. Market is still pricing this as the pre-turnaround IBM carve-out, not as a self-funding services business.
m30
Good earnings quality removes the usual haircut
EQ score is clean (1), so the inflected earnings don't need to be discounted for accounting games — what you see is what's there.
Rich / priced-in 3
m45
Balance sheet in distress zone caps deserved multiple
Altman distress-zone classification means equity holders sit behind real leverage risk. A sub-scale, levered services business deserves a low-single-digit EBITDA multiple, not a re-rate to peers.
m35
Top line still shrinking
Revenue is still declining — until that stabilizes, any DCF is extrapolating off a falling base, which justifies the market's skepticism and limits how much 'cheap' you can claim.
m25
e2e fair value flagged 'Disconnected from Fundamentals'
I'm discounting the composite fair value — methods are diverging, which usually means one or two are runaway and shouldn't be cited as proof of cheapness.
Modestly cheap, not a screaming buy. At $11.28 I'm getting a real but bounded gap — maybe 20–30% to a deserved $13–16 — and I'm paying for that with balance-sheet risk and a still-shrinking top line. I'd want it under $9 before I called it a fat pitch, because a sub-scale levered IT services carve-out doesn't deserve a peer multiple even if the turnaround is real. Today it's a reasonable hold for the inflection, not a table-pounder.
Verify before trusting this (5)
  • FY guidance on revenue stabilization — is the decline narrowing toward flat?
  • Net debt trajectory and any refinancing schedule that would re-rate balance-sheet risk
  • Signings book-to-bill and AI/cloud consulting bookings mix vs legacy run-off
  • Free cash flow conversion sustainability — is the inflection durable or working-capital-aided?
  • Segment-level margin disclosure to confirm the 4% op margin is structural, not mix-driven
Two lenses kept deliberately separate — Company Quality is price-agnostic; Valuation is price-conditional. The scores are not blended (yet). Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Community AI Feedback
No community reviews yet for KD. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.330 · 344c2a54 · 2026-06-09 20:20:16